The Impact of Large-Scale Expansion on the Functional Properties of Mesenchymal Stem Cells
Authors:
- Guadalupe Antonio-RíosGAGuadalupe Antonio-Ríos
- Rosa María Ribas-AparicioRRRosa María Ribas-Aparicio
- Gerardo Leyva-GómezGerardo Leyva-Gómez
- Gloria SoldevilaGSGloria Soldevila
- Karla Alejandra Espinoza DueñasKDKarla Alejandra Espinoza Dueñas
- Cynthia Georgina Trejo-IriarteCTCynthia Georgina Trejo-Iriarte
- Maykel González-TorresMaykel González-Torres
Open Access
- 6 February 2026
- journal article
- review article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (3) , 1051-1066
Abstract
Mesenchymal stem cells (MSCs) are highly valuable for their potential in cell therapy and tissue engineering because of their self-renewal, multilineage differentiation, and immunomodulatory capabilities. Adipose-derived mesenchymal stem cells (AD-MSCs) are advantageous in regenerative medicine because of their accessibility and ease of isolation. However, the clinical application of MSCs faces challenges related to large-scale culture (LSC) expansion, which is required to generate enough cells for transplantation but also decreases their therapeutic properties. This review assesses the impact of LSC on MSC functionality, differentiation potential, and immunomodulatory properties, and identifies key factors, such as metabolic shifts, genetic instability, and altered secretory profiles, that can compromise their therapeutic potential. We explored how prolonged in vitro passaging decreases MSC functionality and increases the risk of genetic alterations. In addition, strategies to preserve the efficacy of MSCs during scaling are discussed. A comprehensive literature review was conducted using PubMed, focusing on in vitro and in vivo studies that evaluated the effects of LSC on MSCs. These findings provide insights into optimizing culture protocols to maintain the clinical efficacy of AD-MSCs in regenerative therapies, addressing the critical need to balance large-scale expansion and functional integrity. Graphical AbstractKeywords
This publication has 86 references indexed in Scilit:
- Manufacturing of primed mesenchymal stromal cells for therapyNature Biomedical Engineering, 2019
- Isolation of Adipose Tissue–Derived Stem Cells: Enzymatic Digestion in Combination with Mechanical Distortion to Increase Adipose Tissue–Derived Stem Cell Yield from Human Aspirated FatCurrent Protocols in Stem Cell Biology, 2018
- Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challengesApplied Microbiology and Biotechnology, 2018
- 2D and 3D cell cultures – a comparison of different types of cancer cell culturesArchives of Medical Science, 2016
- Adipose-derived stem cells: Implications in tissue regenerationWorld Journal of Stem Cells, 2014
- Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practicesTransfusion, 2013
- Mesenchymal stem cells: a new trend for cell therapyActa Pharmacologica Sinica, 2013
- Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsTransplantation, 2003
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsExperimental Hematology, 2003
- Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliBlood, 2002